A carregar...
Effects of Risperidone and Galantamine treatment on Alzheimer biomarker levels in cerebrospinal fluid
BACKGROUND: Treatment for neuropsychiatric symptoms (NPS) in dementia is insufficient. Antipsychotics and acetylcholinesterase inhibitors are used generating symptomatic improvements in behaviour and cognition, but few studies have investigated their effect on Alzheimer biomarkers in cerebrospinal f...
Na minha lista:
| Publicado no: | J Alzheimers Dis |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6203339/ https://ncbi.nlm.nih.gov/pubmed/28269767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160758 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|